Somatic mutations in the H3.3–ATRX–DAXX chromatin-assembly pathway have been identified in 44% of pediatric glioblastoma tumors, suggesting that these mutations might be “driver” mutations for this type of cancer [60]. This evidence concerns the gene ATRX and cancer.